Are Bigger Ad Policy Changes Coming After US FDA’s Drug Promotion Office Hit Hard By Layoffs?

 
• By Sue Sutter
  
Delayed sign
Advisory comments on promotional material submissions may be delayed by the personnel cuts in OPDP. (Shutterstock)

More from Marketing & Advertising

More from Agency Leadership